Complete response after treatment with first-line targeted anti-vascular endothelial growth factor therapy in metastatic renal cancer: what next?
2017 ◽
Vol 25
(7)
◽
pp. 2055-2062
◽
2016 ◽
Vol 254
(8)
◽
pp. 1651-1652
◽
2016 ◽
Vol 57
(4)
◽
pp. 1798
◽